| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 12/24/2013 | DE102012210598A1 Verfahren und Anordnung zur Detektion von Zellen in einer Zellsuspension Method and arrangement for the detection of cells in a cell suspension |
| 12/24/2013 | DE102012111480A1 Verfahren und Vorrichtung zum Prüfen mindestens eines Fluids A method and apparatus for testing at least one fluid |
| 12/24/2013 | DE102012012504A1 Pneumatic component e.g. pneumatic low-pass filter for sampling gas fluctuations at gas sensor for use in ventilation and anesthesia equipment, has restriction component and large flow chamber that partially include common component |
| 12/24/2013 | DE102012012380A1 Motoring device for waste water or turbid media, has optical sensor and light source in position fixed to sensor, where optical sensor is formed in form of digital camera with image memory for frames |
| 12/24/2013 | DE102007046615B4 Gelträger zur Durchführung des COMET-Assays mit Automatisierungsmöglichkeit im Roboter-gestützten Analysebetrieb zur Realisierung eines Hochdurchsatz-Verfahrens Gel support for the implementation of the COMET assay with possibilities for automation in robot-assisted analysis operation for realizing a high-throughput method |
| 12/24/2013 | CA2775651C Methods and apparatus for designing a cement composition |
| 12/24/2013 | CA2736605C System for measuring material properties from a moving construction vehicle |
| 12/24/2013 | CA2707684C Novel exoenzyme toxin of aeromonas salmonicida, and uses therefor |
| 12/24/2013 | CA2702582C Feline pancreatic lipase |
| 12/24/2013 | CA2609558C Identification of compounds modifying a cellular response |
| 12/24/2013 | CA2595476C Method for detecting and removing endotoxin |
| 12/24/2013 | CA2585548C Method and device for measuring the temperature of a molten metal bath |
| 12/24/2013 | CA2552112C Protein detection system |
| 12/24/2013 | CA2536491C Muteins of tear lipocalin |
| 12/24/2013 | CA2485988C Methods of modulating tubulin deacetylase activity |
| 12/24/2013 | CA2481323C Biological substance-immobilized gel and microarray using the same |
| 12/24/2013 | CA2457461C Complement pathway inhibitors binding to c5 and c5a without preventing the formation of c5b |
| 12/24/2013 | CA2424197C Test strip vial |
| 12/24/2013 | CA2397199C Nogo receptor-mediated blockade of axonal growth |
| 12/24/2013 | CA2375104C Prevention and treatment of amyloidogenic disease |
| 12/24/2013 | CA2359362C Methods for customizing pet food |
| 12/24/2013 | CA2302484C Cultures of human cns neural stem cells |
| 12/21/2013 | CA2820660A1 Measurement and process control techniques for dewatering of thick fine tailings |
| 12/19/2013 | WO2013188879A1 Measurement of serum lipoproteins |
| 12/19/2013 | WO2013188864A2 Anti-cd22 anti-idiotypic antibodies and uses thereof |
| 12/19/2013 | WO2013188860A1 Methods and compositions for personalized medicine by point-of-care devices for fsh, lh, hcg and bnp |
| 12/19/2013 | WO2013188853A2 Method and apparatus for analysing composition of hydrocarbon and carbon dioxide gases liberated from drilling fluids |
| 12/19/2013 | WO2013188846A1 Methods of detecting diseases or conditions |
| 12/19/2013 | WO2013188841A1 Chip set-up and high-accuracy nucleic acid sequencing |
| 12/19/2013 | WO2013188840A1 Compositions and methods for sensitive mutation detection in nucleic acid molecules |
| 12/19/2013 | WO2013188789A2 Genome-wide method of assessing interactions between chemical entities and their target molecules |
| 12/19/2013 | WO2013188767A1 Method and system for measuring the pharmacokinetics of liposomal curcumin and its metabolite tetrahydrocurcumin |
| 12/19/2013 | WO2013188765A1 System and apparatus for porously-encapsulated magnetic-nanoparticle biosensors |
| 12/19/2013 | WO2013188756A1 Oligonucleotide-mediated quantitative multiplexed immunoassays |
| 12/19/2013 | WO2013188755A2 Compositions and methods for non-invasive detection and treatment of hypoxic cells in vivo |
| 12/19/2013 | WO2013188699A1 Compositions, methods and devices for activating an immune response |
| 12/19/2013 | WO2013188686A2 Biomarker test for prediction or early detection of preeclampsia and/or hellp syndrome |
| 12/19/2013 | WO2013188675A1 Systems, sensing devices and methods for detection of airborne contaminants |
| 12/19/2013 | WO2013188635A2 Novel methods of identifying proteins via n-terminal tagging and selective pull-down |
| 12/19/2013 | WO2013188623A2 Methods for predicting cardiotoxicity |
| 12/19/2013 | WO2013188605A2 Predictive markers for cancer and metabolic syndrome |
| 12/19/2013 | WO2013188600A1 Copy number aberration driven endocrine response gene signature |
| 12/19/2013 | WO2013188500A1 Whole cell assays and methods |
| 12/19/2013 | WO2013188491A1 Polynucleotide probe design |
| 12/19/2013 | WO2013188469A2 Pathways characterization of cells |
| 12/19/2013 | WO2013188436A1 System and method for detecting cancer |
| 12/19/2013 | WO2013188406A1 Assays of chromatin mediated transcription modulation and compositions used therein |
| 12/19/2013 | WO2013188391A2 Biomarkers for ovarian cancer |
| 12/19/2013 | WO2013188356A1 Food safety indicator |
| 12/19/2013 | WO2013188333A1 Biomarkers related to nephrotoxicity and methods using the same |
| 12/19/2013 | WO2013188124A1 Methods for predicting dynamic sag using viscometer/rheometer data |
| 12/19/2013 | WO2013187850A1 Use of edta tube with gel in elisa method |
| 12/19/2013 | WO2013187784A1 Method and device for assessing the surface condition of rubber or plastic strands |
| 12/19/2013 | WO2013187765A2 Methods, reagents and kits for detecting minimal residual disease |
| 12/19/2013 | WO2013187639A1 Biosensor and measuring device |
| 12/19/2013 | WO2013187638A1 Measuring device |
| 12/19/2013 | WO2013187549A1 Method for measuring mixing ratio of cellulose-based fiber mixed product using chemical carbonization method |
| 12/19/2013 | WO2013187398A1 Support for antibody purification, manufacturing method for same, and application for same |
| 12/19/2013 | WO2013187382A1 Sample isolation particle, sample isolation device and sample isolation method |
| 12/19/2013 | WO2013187371A1 Method for detecting cancer, and antibody capable of recognizing pancreas-specific ribonuclease 1 |
| 12/19/2013 | WO2013187302A1 Test paper |
| 12/19/2013 | WO2013187210A1 Automatic analysis apparatus |
| 12/19/2013 | WO2013187148A1 Image processing device, microscope system, endoscope system, and image processing method |
| 12/19/2013 | WO2013187052A1 Anti-colon cancer agent |
| 12/19/2013 | WO2013186946A1 Method for selecting pluripotent stem cell |
| 12/19/2013 | WO2013186885A1 Method for detecting specific substances in milk |
| 12/19/2013 | WO2013186748A1 A method and a kit for the in vitro diagnosis of pancreatic ductal adenocarcinoma or for determining the predisposition to pancreatic ductal adenocarcinoma |
| 12/19/2013 | WO2013186679A1 A liposomal composition comprising a sterol-modified lipid and a purified mycobacterial lipid cell wall component and it's use in the diagnosis of tuberculosis |
| 12/19/2013 | WO2013186565A1 Biomarker of renal dysfunction |
| 12/19/2013 | WO2013186564A1 Biomarker of renal dysfunction |
| 12/19/2013 | WO2013186562A1 Biomarkers for psychotic disorders, like depression and anxiety disorder |
| 12/19/2013 | WO2013186482A1 In vitro diagnosis device and uses thereof |
| 12/19/2013 | WO2013186422A1 Method for screening and/or evaluating the efficacy of medicaments for the treatment of mitochondrial diseases and melas syndrome |
| 12/19/2013 | WO2013186399A1 V1b receptor antagonist for use in the treatment of patients having an elevated avp level and/or an elevated copeptin level |
| 12/19/2013 | WO2013186374A1 Method for quantifying immune cells in tumoral tissues and its applications |
| 12/19/2013 | WO2013186359A1 Analysis method on the basis of an array |
| 12/19/2013 | WO2013186187A1 Proof of the viability of biological specimens |
| 12/19/2013 | WO2013186171A1 Test station for portable gas measurement devices |
| 12/19/2013 | WO2013186152A1 Pc-o 42:4 - a biomarker for visceral adiposity |
| 12/19/2013 | WO2013186151A1 Pc-o 44:4 - a biomarker for visceral adiposity |
| 12/19/2013 | WO2013186149A1 Pc-o 44:6 - a biomarker for visceral adiposity |
| 12/19/2013 | WO2013186131A1 Test station for a portable gas measuring device |
| 12/19/2013 | WO2013186104A1 Medical device and method for displaying medical data by a medical device |
| 12/19/2013 | WO2013186049A1 Method and arrangement for marking cells in a suspension of cells |
| 12/19/2013 | WO2013185987A1 Susceptibility to and stratification for monoaminergic antidepressants |
| 12/19/2013 | WO2013185884A1 Protein expression analyses for identifying genotoxic compounds |
| 12/19/2013 | WO2013185771A1 Assays for detecting glucosidase activity |
| 12/19/2013 | WO2013185621A1 Endotoxin detection systems and detection methods thereof |
| 12/19/2013 | WO2013185552A1 Dual-signal independent chimeric antigen receptor and use thereof |
| 12/19/2013 | WO2013185440A1 Method for manufacturing gas sensor based on dye-sensitized tio2 film |
| 12/19/2013 | WO2013185249A1 Rating a presumed cleaning process of an elongated textile test material |
| 12/19/2013 | WO2013185248A1 Comparing the quality of elongate textile samples |
| 12/19/2013 | WO2013185247A1 Location-related characterization of the quality of an elongated textile test material |
| 12/19/2013 | WO2013185246A1 Comparing the quality of elongate textile samples |
| 12/19/2013 | WO2013185245A1 Characterization of regular events in an elongated textile test material |
| 12/19/2013 | WO2013185239A1 Transgenic mouse models for mc4r |
| 12/19/2013 | WO2013185215A1 Antibodies and conjugates that target misfolded prion protein |
| 12/19/2013 | WO2013185194A1 Nitrated cardiac troponin i as a biomarker of cardiac ischemia |
| 12/19/2013 | WO2013185193A1 Method for producing and obtaining variable domains of anti-digoxin monoclonal antibody fab fragment using the molecular biology cloning technique |
| 12/19/2013 | WO2013185181A1 Diagnostic method for diseases characterised by ro/la autoimmunity |